Non-vitamin K oral anticoagulants like dabigatran may be advantageous for urgent anticoagulation in patients with acute ischemic stroke, LV thrombus, and AF due to rapid onset and lower bleeding risk.
No takes yet. Share an insight, caveat, or question.
Supports NOAC consideration in select acute stroke cases with LV thrombus; hypothesis-generating and should not change practice without RCTs.
Chung et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: